Warf 2 Tablet contains Warfarin 2 mg, an oral anticoagulant used to prevent and treat thromboembolic disorders. Warfarin acts by inhibiting the synthesis of vitamin K-dependent clotting factors II, VII, IX, and X, as well as anticoagulant proteins C and S, thereby reducing blood coagulation and preventing the formation of harmful clots. It is commonly prescribed for conditions such as deep vein thrombosis (DVT), pulmonary embolism (PE), atrial fibrillation with embolization risk, and for the prevention of stroke in patients with mechanical heart valves. Warf 2 Tablet requires careful dose adjustment and regular monitoring of the International Normalized Ratio (INR) to maintain therapeutic anticoagulation while minimizing the risk of bleeding complications. Patients should be advised to maintain consistent dietary vitamin K intake and inform healthcare providers of all concomitant medications, as numerous drug interactions may affect Warfarin’s efficacy and safety. Caution is warranted in patients with bleeding disorders, hepatic impairment, or those undergoing surgery. Adverse effects primarily include bleeding events, ranging from minor bruising to severe hemorrhage. Warf 2 Tablet should be used under strict medical supervision with appropriate patient education to ensure optimal therapeutic outcomes and safety.